美股新聞 標題聯播 · 近 24 小時 284 則 · 25 個來源 · 最新 9/20 06:32
本站只列標題、來源、時間與原文連結,不重製內文;著作權屬原媒體與原作者。新聞稿通路(PR Newswire、Business Wire、GlobeNewswire)是公司自己發的,屬第一手;媒體是轉述。
全部 · ANAB近 30 天 2 則 · 第 1 / 1 頁
- Alphyn Capital on Its Special-Situation Investment: AnaptysBio (ANAB)
- Anaptys Announces Participation at the H.C. Wainwright 28th Annual Global Investment Conference
- GSK Eyes AnaptysBio (ANAB) Acquisition to Secure Drug Control
- What Makes AnaptysBio (ANAB) an Investment Bet?
- Is AnaptysBio (ANAB) Outperforming Other Medical Stocks This Year?
- Wall Street Analysts See a 38.75% Upside in AnaptysBio (ANAB): Can the Stock Really Move This High?
- How The Grupo Traxión (BMV:TRAXION A) Story Is Shifting With Cautious New Analyst Targets
- Anaptys Announces First Quarter 2026 Financial Results and Provides Business Update
- Anaptys Appoints Chris Murphy as Chief Financial Officer and Owen Hughes to Board of Directors
- Assessing AnaptysBio (ANAB) Valuation After Royalty Pivot Spinoff And Legal Outcome
- Is AnaptysBio (ANAB) One of the Best Performing Healthcare Stocks so Far in 2026?
- Why These Four Biotech Stocks Prove That Follow-On Entries Still Pop Up In Stock Market Leaders
- Nektar Q1 Earnings & Revenues Lag Estimates, Pipeline in Focus
- PBYI Q1 Earnings & Sales Beat Estimates, 2026 Guidance Raised
- Zoetis Q1 Earnings Lag Estimates, 2026 View Cut, Stock Down
- TGTX Q1 Earnings Miss, Sales Rise Y/Y, Stock Up on Raised 2026 View
- Mirum's Q1 Earnings & Revenues Beat Estimates, 2026 View Raised
- Are Medical Stocks Lagging AnaptysBio (ANAB) This Year?
中文標題是機器翻譯(NLLB 模型,不外送資料),專有名詞靠對照表,語意以英文原題為準。預設藏掉:選股文與自動生成站(Motley Fool、24/7 Wall St、Trefis、MarketBeat…)、加密幣、律師事務所的股東訴訟廣告、非英文、新聞稿裡的人事任命 / 出席活動 / 得獎、個人理財專欄,以及通路稿標題對不到上市公司的。個股標籤是從標題辨識的(通路標準寫法 (NASDAQ: NVDA)、公司名對照);帶「?」的是從摘要辨識、信心較低。來源等級 A / B / C 只影響精選排序,不是對媒體的評價。